Sarepta Therapeutics, Inc. Message Board

long and holding.

CNBC MARKET INSIDER
After-Hours Buzz: ADBE, WSM, CTAS & More Published: Tuesday, 19 Mar 2013 | 4:40 PM ET
By: JeeYeon Park
Sarepta Therapeutics - William Blair initiated coverage of the medical research and drug development company with an "outperform" rating and a price target of $52, sending shares higher in extended-hours trading..

BlackBerry Soars on Major Order Win
ZacksBy Zacks Equity Research | Zacks
We believe this is a big impetus for BBRY and shows the confidence the customers have in its as yet untested operating platform. Recently, the company announced that it has witnessed strong customer switch from other OS platforms to their latest BB10-based device.

This massive order win will be a major boost to the company’s top line in the coming quarters and readjust its position in the smartphone market. However, the company still has to vend off competition from Samsung Electronics’ latest gadget S4, which is expected to be launched Mar 14, 2013.

Wall Street Cheat Sheet March 14, 2013
By: Leah Powell
BlackBerry (NASDAQ:BBRY): Verizon Wireless (NYSE:VZ) stated that it has intentions to start to seel the new BlackBerry Z10 smartphone in the U.S. on March 28, which is nearly a week after its rival AT&T (NYSE:T) will launch the device. Verizon stated that it will start to take pre-orders for the new smartphone on Thursday, March 14. The carrier is expected will offer a white version of the device that will be exclusive to its network. Furthermore, BlackBerry announced that an unnamed customer placed an order for 1 million BlackBerry 10 devices, but it did not specify the amount of the Z10 and the amount that there were for the yet-to-be-launched Q10 device that features a QWERTY physical keyboard.

it's a joke

Yahoo Finance 3/8/13